To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Already have an account?
University of Toledo Professor Recognized for Excellence in Peptide Chemistry
Read time: 1 minute
The renowned peptide scientist, Dr. Maurice Manning, received the 2010 Meienhofer Award for Excellence in Peptide Chemistry at the annual Roche Colorado Corporation Peptide Symposium (RCCPS).
For more than four decades, Dr. Maurice Manning has championed the exploration of peptides as potential therapeutic agents. His work has advanced the development of peptides for the treatment of autism spectrum disorders as wells as anxiety and stress.
Dr. Manning’s laboratory at the University of Toledo currently is focused on the design and solid phase synthesis of peptide ligands for Oxytocin and Vasopressin receptors. Dr. Manning supplies these compounds of interest to longtime collaborators and other scientists around the world.
Dr. Manning received his Ph.D. in 1961 from the University of London in Organic Chemistry. In 1974, Dr. Manning earned the prestigious Doctorate in Science in Peptide Chemistry from the University College Galway (now the National University of Ireland). Dr. Manning began his illustrious academic career at the Cornell University Medical College in New York and would move to subsequent positions at Rockefeller University, and McGill University before settling at the University of Toledo College of Medicine.
Upon learning that he received the Meienhofer Award, Dr. Manning responded, “Hans Meienhofer was a giant in the Peptide Field and a dear friend. I have so many memories of his warm and gracious personality and of his extraordinary contributions to the peptide field. I am thus highly honored and deeply flattered by being selected as the 2010 recipient of this prestigious Award and to join the company of previous recipients: Dan Kemp, Andrew Schally, and most recently, my dear friend Waleed Danho.”
Distinguished scientist and 2009 Meienhofer Award recipient, Dr. Waleed Danhoe, responded in kind, “Johannes Meienhofer would be please to see his friend Maurice receiving this special recognition. He is the perfect candidate and his lifetime of achievements brings honor to the Meienhofer Award.”
For more than four decades, Dr. Maurice Manning has championed the exploration of peptides as potential therapeutic agents. His work has advanced the development of peptides for the treatment of autism spectrum disorders as wells as anxiety and stress.
Dr. Manning’s laboratory at the University of Toledo currently is focused on the design and solid phase synthesis of peptide ligands for Oxytocin and Vasopressin receptors. Dr. Manning supplies these compounds of interest to longtime collaborators and other scientists around the world.
Dr. Manning received his Ph.D. in 1961 from the University of London in Organic Chemistry. In 1974, Dr. Manning earned the prestigious Doctorate in Science in Peptide Chemistry from the University College Galway (now the National University of Ireland). Dr. Manning began his illustrious academic career at the Cornell University Medical College in New York and would move to subsequent positions at Rockefeller University, and McGill University before settling at the University of Toledo College of Medicine.
Upon learning that he received the Meienhofer Award, Dr. Manning responded, “Hans Meienhofer was a giant in the Peptide Field and a dear friend. I have so many memories of his warm and gracious personality and of his extraordinary contributions to the peptide field. I am thus highly honored and deeply flattered by being selected as the 2010 recipient of this prestigious Award and to join the company of previous recipients: Dan Kemp, Andrew Schally, and most recently, my dear friend Waleed Danho.”
Distinguished scientist and 2009 Meienhofer Award recipient, Dr. Waleed Danhoe, responded in kind, “Johannes Meienhofer would be please to see his friend Maurice receiving this special recognition. He is the perfect candidate and his lifetime of achievements brings honor to the Meienhofer Award.”
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
